Synapedia

Translated automatically – community improvements welcome.

Donepezil

Donepezil is a selective acetylcholinesterase inhibitor used for the treatment of cognitive symptoms in Alzheimer's disease. It increases the availability of acetylcholine in the brain and can thereby improve memory and attention. The substance has a moderate side effect profile, which may primarily include gastrointestinal discomfort.

Nootropika
Nootropika
Acetylcholinesterase

Mechanism of Action

  • Acetylcholinesterase inhibitor

Names / Identifiers

IUPAC: Donepezil

Mechanism of Action

Mechanism of action of Donepezil (Unknown): Data is being researched.

Effects

Verbesserung der kognitiven Funktion
Erhöhung der Gedächtnisleistung
Steigerung der Aufmerksamkeit
Verbesserung der cholinergen Transmission
Reduktion von Verwirrtheit

Effects described from scientific sources. Individual experiences vary.

Dosage

Safety NoteIndividual variation, start at a low dose, no medical advice.

Individual sensitivity varies. Not a dosage recommendation.

Duration

Peak3-4 hours
NotesEffects may vary depending on the person.
Onset1-2 hours
Total24 hours
After EffectsMild cognitive influence possible

Risks & Warnings

Warnings

  • Pregnancy and breastfeeding.
  • Severe liver or kidney disease.

Known Risks

  • medium
  • Nebenwirkungen können Übelkeit, Durchfall und Schlafstörungen umfassen.

Safer Use

  • Start at a low dose.
  • Consider regular medical check-ups.

Harm reduction tips do not replace medical advice.

Known Interactions

  • May interact with other cholinergic medications.
  • Caution when taken concurrently with non-steroidal anti-inflammatory drugs (NSAIDs).

This list is not exhaustive. Interactions can have unpredictable effects.

Legal Status

ATVerschreibungspflichtig
CHVerschreibungspflichtig
DEVerschreibungspflichtig
USVerschreibungspflichtig
NotesDonepezil ist in vielen Ländern zur Behandlung von Alzheimer-Krankheit zugelassen.

Not legal advice. Status may change.